CATALOGO DEI PRODOTTI DELLA RICERCA

MARASTONI, DAMIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.109
EU - Europa 2.100
AS - Asia 1.628
SA - Sud America 280
AF - Africa 95
OC - Oceania 7
Totale 6.219
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.032
RU - Federazione Russa 1.072
SG - Singapore 667
CN - Cina 328
IT - Italia 292
BR - Brasile 223
VN - Vietnam 190
GB - Regno Unito 146
HK - Hong Kong 143
DE - Germania 114
FI - Finlandia 92
FR - Francia 84
SE - Svezia 81
IE - Irlanda 70
TR - Turchia 60
CA - Canada 46
KR - Corea 44
ID - Indonesia 35
IN - India 32
NL - Olanda 32
JP - Giappone 23
BD - Bangladesh 22
AT - Austria 21
MX - Messico 21
PL - Polonia 21
EG - Egitto 20
AR - Argentina 18
UA - Ucraina 18
TG - Togo 15
ZA - Sudafrica 15
BJ - Benin 14
ES - Italia 13
IQ - Iraq 13
NG - Nigeria 11
CO - Colombia 10
IR - Iran 10
EC - Ecuador 9
CH - Svizzera 8
UZ - Uzbekistan 7
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
BE - Belgio 5
CL - Cile 5
PY - Paraguay 5
HR - Croazia 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
RS - Serbia 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
IL - Israele 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
BY - Bielorussia 2
CG - Congo 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GY - Guiana 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
QA - Qatar 2
SC - Seychelles 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
Totale 6.213
Salva come PNG Salva come JPEG
Città #
Moscow 386
Ashburn 381
Singapore 344
San Jose 251
Chandler 204
Dallas 189
Hong Kong 143
Verona 129
The Dalles 87
Dublin 67
Beijing 63
Los Angeles 61
Southend 59
Ho Chi Minh City 56
New York 53
Helsinki 52
Istanbul 41
Redmond 39
Munich 36
São Paulo 32
Hanoi 30
London 29
Princeton 29
Jakarta 27
Lappeenranta 27
Montreal 25
Council Bluffs 23
Jacksonville 23
Buffalo 22
Lawrence 22
Orem 21
Dong Ket 20
Tokyo 20
Warsaw 20
Milan 18
Redondo Beach 18
Amsterdam 17
Sindelfingen 16
Atlanta 15
Lomé 15
Cotonou 14
Phoenix 14
Santa Clara 14
Columbus 13
Nuremberg 13
Poplar 13
Chicago 12
Frankfurt am Main 12
Haiphong 12
Tianjin 12
Turku 12
Wilmington 12
Brooklyn 11
Falkenstein 11
Jinan 11
Johannesburg 11
Seattle 11
Stockholm 11
Woodbridge 11
Abuja 10
Cairo 10
Chennai 10
Rome 10
Toronto 10
Vienna 10
Ankara 9
Da Nang 9
Denver 9
Guangzhou 9
Houston 9
Ann Arbor 8
Bologna 8
Mexico City 8
Paris 8
Washington 8
City of London 7
East Lansing 7
Manchester 7
Redwood City 7
Taizhou 7
Baghdad 6
Chirignago 6
Mumbai 6
Nanjing 6
Piscataway 6
Querétaro 6
Rio de Janeiro 6
San Francisco 6
Seoul 6
Tashkent 6
Baku 5
Biên Hòa 5
Dhaka 5
Duncan 5
Kyiv 5
Norwalk 5
Porto Alegre 5
Shenyang 5
Taiyuan 5
Zhengzhou 5
Totale 3.630
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid IgM levels in association with inflammatory pathways in multiple sclerosis patients 217
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients 214
The CSF profile linked to cortical damage predicts Multiple Sclerosis activity 210
A case of multiple sclerosis and necrotizing autoimmune myopathy with anti-SRP antibodies 200
IMMUNOPATHOLOGY OF INTRATHECAL INFLAMMATION IN MULTIPLE SCLEROSIS: CLINICAL, RADIOLOGICAL AND IMMUNOLOGICAL CORRELATES 185
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis 183
The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study 180
Increase of CSF inflammatory profile in a case of highly active multiple sclerosis 168
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis 165
CSF levels of CXCL12 and osteopontin as early markers of primary progressive multiple sclerosis 164
Changes in cerebrospinal fluid balance of TNF and TNF receptors in naïve multiple sclerosis patients: early involvement in compartmentalised intrathecal inflammation 162
Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis 158
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS 158
Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy 157
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs 152
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study 152
CSF Parvalbumin Levels at Multiple Sclerosis Diagnosis Predict Future Worse Cognition, Physical Disability, Fatigue, and Gray Matter Damage 148
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 148
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter 146
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple Sclerosis 144
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis 143
Cortical lesions at diagnosis predict long-term cognitive impairment in multiple sclerosis: a 20-year study 138
"Ependymal-in" gradient of thalamic damage in progressive multiple sclerosis 137
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 136
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis 131
Cluster analysis showed long-term cognition can be predicted by looking at regional grey matter atrophy in the first two years of multiple sclerosis course 127
Intrathecal versus peripheral inflammatory protein profile in MS patients at diagnosis: a comprehensive investigation on serum and CSF 126
Multiple sclerosis diagnosis and its differential diagnosis in patients presenting with type four 'mirror pattern' CSF oligoclonal bands 124
Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study 121
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients 120
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse? 120
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis 119
Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature 118
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients 118
Cortical surface-in gradient of alterations in magnetization transfer imaging in association with CSF soluble factors 111
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis 110
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis 107
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients 105
The effect of air pollution on {COVID}-19 severity in a sample of patients with multiple sclerosis 101
The BAFF / APRIL system as therapeutic target in multiple sclerosis 98
Prominent role of executive functioning on the Phonemic Fluency Test in people with multiple sclerosis 75
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 73
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 73
High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective post-mortem cohort study 72
Unsupervised Clustering Based on Quantitative Magnetic Resonance Imaging Features Contributes to the Characterization of MS White Matter Lesions 38
Choroid plexus volume predicts progression independent of relapse activity in early relapsing multiple sclerosis 34
Quantitative Magnetic resonance imaging lesion features allow machine learning-based classification of MS patients with Progression Independent of Relapse Activity 27
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosis 27
Cognition beyond relapses: cognitive progression independent of relapse activity reflects early smoldering neurodegeneration in multiple sclerosis 26
Ofatumumab Versus Intravenous Ocrelizumab after Sphingosine-1-Phosphate Receptor Modulators in Patients with Relapsing-Remitting Multiple Sclerosis: A Real-World Inverse Probability of Treatment Weighting Multicenter Study 20
Dynamic emotion recognition and authenticity detection in multiple sclerosis: preliminary cognitive, behavioral, and neuroimaging evidence 12
Real-world effectiveness and safety of ofatumumab in multiple sclerosis: a longitudinal study integrating clinical, cognitive, and MRI outcomes 5
Totale 6.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.670
article - articoli 20.770
book - libri 0
conference - conferenze 570
curatela - curatele 0
other - altro 330
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 1 18 24
2021/2022217 6 65 0 51 2 1 9 10 5 19 11 38
2022/2023505 33 74 34 93 29 113 5 38 60 3 11 12
2023/2024354 11 20 22 53 29 71 24 13 6 33 58 14
2024/20251.258 55 75 53 212 60 68 85 88 178 76 87 221
2025/20263.723 219 200 221 655 1.061 231 358 211 347 220 0 0
Totale 6.303